Pages that link to "Q42441665"
Jump to navigation
Jump to search
The following pages link to Induction of Apoptosis in Small-Cell Lung Cancer Cells by an Antisense Oligodeoxynucleotide Targeting the Bcl-2 Coding Sequence (Q42441665):
Displaying 50 items.
- Harnessing the apoptotic programs in cancer stem-like cells (Q26801037) (← links)
- Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines (Q28469349) (← links)
- Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family (Q30971455) (← links)
- Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac (Q31156666) (← links)
- Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release. (Q31407508) (← links)
- A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer (Q33395544) (← links)
- Elucidating cell signaling mechanisms using antisense technology (Q33877254) (← links)
- Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer (Q34013850) (← links)
- Therapeutic advances in small cell lung cancer (Q34074764) (← links)
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies. (Q34155620) (← links)
- Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity (Q34301730) (← links)
- Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). (Q34334749) (← links)
- Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer (Q34335607) (← links)
- Antisense oligonucleotide against hTERT (Cantide) inhibits tumor growth in an orthotopic primary hepatic lymphoma mouse model (Q34358498) (← links)
- Gene therapy for lung neoplasms. (Q34569410) (← links)
- Targeting anti-apoptotic genes upregulated by androgen withdrawal using antisense oligonucleotides to enhance androgen- and chemo-sensitivity in prostate cancer (Q34722249) (← links)
- Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin (Q34780639) (← links)
- Antisense therapy for cancer--the time of truth (Q34992794) (← links)
- Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center. (Q35173052) (← links)
- Antisense oligonucleotides for cancer therapy-an overview (Q35179429) (← links)
- Death receptors in chemotherapy and cancer (Q35743149) (← links)
- Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance (Q36254793) (← links)
- Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects (Q36334885) (← links)
- The future of antisense oligonucleotides in the treatment of respiratory diseases (Q36435632) (← links)
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer (Q36709317) (← links)
- Targeted therapies in small-cell lung cancer (Q36897340) (← links)
- Genetic changes in small cell lung carcinoma. (Q37138250) (← links)
- 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro (Q37521252) (← links)
- bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity (Q38347131) (← links)
- In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with α-tocopherol succinate (Q38697575) (← links)
- TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells (Q38737078) (← links)
- EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer (Q38806059) (← links)
- Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer (Q39123831) (← links)
- Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells (Q39475375) (← links)
- BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells (Q40521692) (← links)
- Survivin antisense oligodeoxynucleotide inhibits growth of gastric cancer cells. (Q40569126) (← links)
- Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. (Q40654530) (← links)
- Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine (Q40680294) (← links)
- Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression (Q40697893) (← links)
- Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis (Q40754106) (← links)
- Phosphorylation of the tumor necrosis factor receptor CD120a (p55) recruits Bcl-2 and protects against apoptosis (Q40816786) (← links)
- Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. (Q42442790) (← links)
- Transfer of bcl-xs plasmid is effective in preventing and inhibiting rat hepatocellular carcinoma induced by N-nitrosomorpholine (Q43710403) (← links)
- Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells (Q43792830) (← links)
- In vitro modulation of Bcl-2 levels in small cell lung cancer cells: effects on cell viability. (Q44127620) (← links)
- Remarkable induction of apoptosis in cancer cells by a novel cationic liposome complexed with a bcl-2 antisense oligonucleotide (Q44356541) (← links)
- Simultaneous evaluation of viability and Bcl-2 in small-cell lung cancer. (Q46374655) (← links)
- Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma (Q46647666) (← links)
- Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene (Q47148087) (← links)
- Progress in understanding the molecular pathogenesis of human lung cancer. (Q53431081) (← links)